Clinical Trial Update: E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study [Phase 3]

View source ↗

Summary

Phase 3 trial update for Estetrol/Drospirenone oral contraceptive (E4 FREEDOM) completed in EU/Russia with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• Estetrol/Drospirenone (Estetrol with drospirenone)

Snippet

Sponsor: Estetra | Conditions: Contraception | Phase 3 | Status: COMPLETED | Results posted: 2019-10-04